Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells

M Chen, V Venturi, CML Munier - Biology, 2023 - mdpi.com
Simple Summary Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by
the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The immune paradox of SARS‐CoV‐2: Lymphocytopenia and autoimmunity evoking features in COVID‐19 and possible treatment modalities

J Gerlach, AM Baig, M Fabrowski… - Reviews in Medical …, 2023 - Wiley Online Library
SARS‐CoV‐2 causes multiorgan damage to vital organs and tissue that are known to be
due to a combination of tissue tropisms and cytokine‐mediated damage that it can incite in …

NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins

I Tsukalov, I Sánchez-Cerrillo, O Rajas… - Nature …, 2024 - nature.com
Increased recruitment of transitional and non-classical monocytes in the lung during SARS-
CoV-2 infection is associated with COVID-19 severity. However, whether specific innate …

Gastrointestinal microbiota and metabolites possibly contribute to distinct pathogenicity of SARS-CoV-2 proto or its variants in rhesus monkeys

H Chen, J Wang, K Ding, J Xu, Y Yang, C Tang… - Gut …, 2024 - Taylor & Francis
Gastrointestinal (GI) infection is evidenced with involvement in COVID-19 pathogenesis
caused by SARS-CoV-2. However, the correlation between GI microbiota and the distinct …

The unreversible reduced but persistent activated NK and CD8+ T cells in severe/critical COVID-19 during omicron pandemic in China

L Qin, X Duan, JZ Dong, Y Chang, Y Han… - Emerging microbes & …, 2023 - Taylor & Francis
As a hallmark of COVID-19 progression, lymphopenia alongside its subtle immune
disturbance has been widely reported, but yet to be thoroughly elucidated. Aiming at …

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard …

M Gainullin, L Federico, J Røkke Osen… - Frontiers in …, 2024 - frontiersin.org
People who use drugs (PWUD) are at a high risk of contracting and developing severe
coronavirus disease 2019 (COVID-19) and other infectious diseases due to their lifestyle …

Alterations in the CD56 and CD56+ T Cell Subsets during COVID-19

JD Vavilova, MO Ustiuzhanina, AA Boyko… - International Journal of …, 2023 - mdpi.com
The effectiveness of the antiviral immune response largely depends on the activation of
cytotoxic T cells. The heterogeneous group of functionally active T cells expressing the …

Nanomaterial-Based Biosensors for the Detection of COVID-19

M Tewari, P Rana, V Pande - Indian Journal of Microbiology, 2024 - Springer
The COVID-19 outbreak began in December 2019 and has affected people worldwide. It
was declared a pandemic in 2020 by the World Health Organization. Developing rapid and …

[HTML][HTML] Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3+ T cells from COVID-19 patients

S Abdolmohammadi-Vahid, B Baradaran… - Experimental and …, 2024 - Elsevier
Background Signaling by toll-like receptors (TLRs) initiates important immune responses
against viral infection. The role of TLRs in severe acute respiratory syndrome coronavirus 2 …

A Literature Review and Meta-Analysis on the Potential Use of miR-150 as a Novel Biomarker in the Detection and Progression of Multiple Sclerosis

VC Arcas, AM Fratila, DFC Moga, I Roman-Filip… - Journal of Personalized …, 2024 - mdpi.com
Background: MicroRNA-150 (miR-150) plays a critical role in immune regulation and has
been implicated in autoimmune diseases like Multiple Sclerosis (MS). This review aims to …